BioTech Health XJuly 20, 2022 Biotech NewsMerck Announces Failure in Keytruda Head and Neck Cancer Phase 3 Clinical Trial 3 minute read Today Merck & Co. (NYSE: MRK) announced that Keytruda has failed the Phase 3 clinical trial KEYNOTE-412 evaluating… 0 Shares 0 0 0 0 0 0 0
BioTech Health XMay 23, 2022 Biotech NewsOcugen Announces FDA Clinical Hold Removal for Phase 2/3 COVAXIN (BBV152) Clinical Trial 3 minute read Biotechnology company Ocugen, Inc. (NASDAQ: OCGN) announced today that the U.S. Food and Drug Administration (FDA) has removed… 0 Shares 0 0 0 0 0 0 0
Jak ThomsonSeptember 7, 2021 Biotech NewsMacroGenics Announces Failure in SOPHIA Study of MARGENZA for Metastatic Breast Cancer Patients 3 minute read Biopharma MacroGenics, Inc. (NASDAQ: MGNX) announced that the final overall survival (OS) analysis did not demonstrate a statistically… 0 Shares 0 0 0 0 0 0 0
BioTech Health XJune 28, 2021 Biotech NewsCel-Sci Announces Multikine Immunotherapy Significantly Improves Overall Survival Benefit for Cancer Head & Neck Patients in Phase 3 Trial 3 minute read Data Shows Significant Overall Survival Benefit for Cancer Patients with Multikine Treatment Regimen Followed by Surgery & Radiotherapy… 0 Shares 0 0 0 0 0 0 0